Latest News
Press Release: TILT Biotherapeutics secures over EUR 6 million to advance cancer immunotherapies into clinic
Tuija Keinonen joins TILT as Regulatory consultant
TILT Biotherapeutics was featured Tulevaisuuden työelämä 2020. Read the article in Finnish here.
TILT´s CEO Akseli Hemminki interviewed at JP Morgan Biotech Showcase
TILT varautuminen koronatilanteen aiheuttamiin muutoksiin
TILT preparations during the corona pandemic
Jyrki Liljeroos joins TILT as Board Advisor
Springvest organised investment round
João Santos appointed as a Head of Cell Therapy
TILT Biotherapeutics Signs a Licensing Deal with Biotheus, Inc
Upcoming Events
Please contact our business development team to meet us at the following events:
November 2020
Virtual or on-site at Visitor and Innovation Centre Joki, Turku